PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Up 1,271.7% in May

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a large growth in short interest in May. As of May 15th, there was short interest totaling 51,769 shares, a growth of 1,271.7% from the April 30th total of 3,774 shares. Based on an average daily trading volume, of 347,170 shares, the short-interest ratio is presently 0.1 days.

PharmaTher Stock Down 6.6%

Shares of PHRRF traded down $0.00 during midday trading on Wednesday, reaching $0.05. The stock had a trading volume of 62,500 shares, compared to its average volume of 181,361. PharmaTher has a 52 week low of $0.04 and a 52 week high of $0.55. The firm’s 50 day moving average price is $0.05 and its 200-day moving average price is $0.07.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.